201 related articles for article (PubMed ID: 9266780)
1. Effects of warfarin on markers of hypercoagulability in patients with heart failure.
Jafri SM; Mammen EF; Masura J; Goldstein S
Am Heart J; 1997 Jul; 134(1):27-36. PubMed ID: 9266780
[TBL] [Abstract][Full Text] [Related]
2. Increased hemostatic molecular markers in patients undergoing anticoagulant therapy.
Wada H; Ikuma H; Mori Y; Shimura M; Hiyoyama K; Nakasaki T; Onoda K; Yamada N; Ohta T; Nishioka J; Sakuragawa N; Shiku H
Semin Thromb Hemost; 2000; 26(1):113-8. PubMed ID: 10805292
[TBL] [Abstract][Full Text] [Related]
3. Influence of long term oral anticoagulants upon prothrombin fragment 1 + 2, thrombin-antithrombin III complex and D-Dimer levels in patients affected by proximal deep vein thrombosis.
Elias A; Bonfils S; Daoud-Elias M; Gauthier B; Sié P; Boccalon H; Boneu B
Thromb Haemost; 1993 Apr; 69(4):302-5. PubMed ID: 8497840
[TBL] [Abstract][Full Text] [Related]
4. Prothrombin fragments F1+2, thrombin-antithrombin III complexes, fibrin monomers and fibrinogen in patients with coronary atherosclerosis.
Giannitsis E; Siemens HJ; Mitusch R; Tettenborn I; Wiegand U; Schmücker G; Sheikhzadeh A; Stierle U
Int J Cardiol; 1999 Mar; 68(3):269-74. PubMed ID: 10213277
[TBL] [Abstract][Full Text] [Related]
5. Markers of activated hemostasis and fibrinolysis in patients with pulmonary malignancies: comparison of plasma levels in central venous and pulmonary venous blood.
Kalweit GA; Feindt P; Micek M; Gams E; Hellstern P
Thromb Res; 2000 Feb; 97(3):105-11. PubMed ID: 10680641
[TBL] [Abstract][Full Text] [Related]
6. High F1.2 fragment of prothrombin, thrombin-antithrombin III complex (TAT) and soluble fibrin plasma levels demonstrate hypercoagulability induced during loco-regional thrombolytic therapy with rt-PA.
Garcia-Avello A; Garcia-Frade LJ; Gandarias C; Ocaña J; Cancelas JA; Lasso M
Thromb Res; 1994 Jan; 73(2):109-15. PubMed ID: 8171409
[TBL] [Abstract][Full Text] [Related]
7. Coagulopathy in disseminated intravascular coagulation due to abdominal sepsis: determination of prothrombin fragment 1 + 2 and other markers.
Okamoto K; Takaki A; Takeda S; Katoh H; Ohsato K
Haemostasis; 1992; 22(1):17-24. PubMed ID: 1387863
[TBL] [Abstract][Full Text] [Related]
8. Coagulation activation markers in the prediction of venous thrombosis after elective hip surgery.
Cofrancesco E; Cortellaro M; Corradi A; Ravasi F; Bertocchi F
Thromb Haemost; 1997 Feb; 77(2):267-9. PubMed ID: 9157579
[TBL] [Abstract][Full Text] [Related]
9. Prothrombin fragment 1 + 2, thrombin-antithrombin III complexes and D-dimers in acute deep vein thrombosis: effects of heparin treatment.
Estivals M; Pelzer H; Sie P; Pichon J; Boccalon H; Boneu B
Br J Haematol; 1991 Jul; 78(3):421-4. PubMed ID: 1873225
[TBL] [Abstract][Full Text] [Related]
10. Influence of aging on the activity of the hemostatic system: prothrombin fragment 1+2, thrombin-antithrombin III complexes and D-dimers in 80 healthy subjects with age ranging from 20 to 94 years.
Cadroy Y; Pierrejean D; Fontan B; Sié P; Boneu B
Nouv Rev Fr Hematol (1978); 1992; 34(1):43-6. PubMed ID: 1523099
[TBL] [Abstract][Full Text] [Related]
11. Coagulation activity and clinical outcome in unstable coronary artery disease.
Oldgren J; Linder R; Grip L; Siegbahn A; Wallentin L
Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):1059-64. PubMed ID: 11397720
[TBL] [Abstract][Full Text] [Related]
12. Hypercoagulable state under low-intensity warfarin anticoagulation assessed with hemostatic markers in cardiac disorders.
Takano K; Iino K; Ibayashi S; Tagawa K; Sadoshima S; Fujishima M
Am J Cardiol; 1994 Nov; 74(9):935-9. PubMed ID: 7977125
[TBL] [Abstract][Full Text] [Related]
13. Clinical utility of prothrombin fragment 1+2, thrombin antithrombin III complexes and D-dimer measurements in the diagnosis of deep vein thrombosis following total hip replacement.
Cofrancesco E; Cortellaro M; Corradi A; Ravasi F; Bertocchi F
Thromb Haemost; 1998 Mar; 79(3):509-10. PubMed ID: 9531030
[TBL] [Abstract][Full Text] [Related]
14. Markers of in vivo activation of coagulation. Interrelationships change with intensity of oral anticoagulation.
Solymoss S; Bovill EG
Am J Clin Pathol; 1996 Mar; 105(3):293-7. PubMed ID: 8602609
[TBL] [Abstract][Full Text] [Related]
15. Relationship between changes in F1+2 and TAT levels and blood coagulation early after prosthetic valve replacement.
Nakamura K; Toyohira H; Kariyazono H; Yamada K; Moriyama Y; Taira A
Thromb Res; 1997 Apr; 86(2):161-71. PubMed ID: 9175237
[TBL] [Abstract][Full Text] [Related]
16. Comparison of prothrombin fragment 1 + 2 with thrombin-antithrombin III complex in plasma of patients with disseminated intravascular coagulation.
Takahashi H; Wada K; Niwano H; Shibata A
Blood Coagul Fibrinolysis; 1992 Dec; 3(6):813-8. PubMed ID: 1336986
[TBL] [Abstract][Full Text] [Related]
17. Prothrombin fragment F1 + 2 and thrombin-antithrombin III complex are useful markers of the hypercoagulable state in atrial fibrillation.
Asakura H; Hifumi S; Jokaji H; Saito M; Kumabashiri I; Uotani C; Morishita E; Yamazaki M; Shibata K; Mizuhashi K
Blood Coagul Fibrinolysis; 1992 Aug; 3(4):469-73. PubMed ID: 1420823
[TBL] [Abstract][Full Text] [Related]
18. Activation of blood coagulation after abrupt or stepwise withdrawal of oral anticoagulants--a prospective study.
Palareti G; Legnani C; Guazzaloca G; Frascaro M; Grauso F; De Rosa F; Fortunato G; Coccheri S
Thromb Haemost; 1994 Aug; 72(2):222-6. PubMed ID: 7831656
[TBL] [Abstract][Full Text] [Related]
19. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
[TBL] [Abstract][Full Text] [Related]
20. Detection of a hypercoagulable state in nonvalvular atrial fibrillation and the effect of anticoagulant therapy.
Mitusch R; Siemens HJ; Garbe M; Wagner T; Sheikhzadeh A; Diederich KW
Thromb Haemost; 1996 Feb; 75(2):219-23. PubMed ID: 8815563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]